SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: Sodium (6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(Z)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (as per EP);Sodium (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 72-(Z)-(O-methyloxime), carbamate (ester) (as per USP)
异名: Cefuroxime Axetil EP Impurity D
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: [H][C@]1(SCC(COC(N)=O)=C2C([O-])=O)N2C([C@H]1NC(/C(C3=CC=CO3)=N/OC)=O)=O.[Na+]
Cefuroxime Sodium is chemically Sodium (6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(Z)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (as per EP);Sodium (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 72-(Z)-(O-methyloxime), carbamate (ester) (as per USP). It is also known as Cefuroxime Axetil EP Impurity D. Cefuroxime Sodium is supplied with detailed characterization data compliant with regulatory guideline. Cefuroxime Sodium can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefuroxime.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Liquid chromatography-tandem mass spectrometry method for the determination of cefuroxime axetil diastereoisomers: application to stability-indicating method
By Sharaf El-Din, Mohie M. K.; Nassar, Mohamed W. I.; Attia, Khalid A. M.; El Demellawy, Maha A.; Kaddah, Mohamed M. Y.
From Journal of the Iranian Chemical Society (2021), 18(9), 2505-2515
Content determination of cefuroxime in peritoneal dialysis solution by HPLC and compatible stability of the mixture
By Li, Cheng; Wu, Xiao-juan; Feng, Lian-jie; Mai, Jia-hui; Zhang, Kai-li
From Zhongguo Yaofang (2012), 23(25), 2378-2379
Specific stability indicating assay method for the determination of cefuroxime sodium in pharmaceutical formulation by UV-Vis Spectrophotometer
By Devkhile, A. B.; Shaikh, K. A.
From International Journal of Pharmacy and Technology (2011), 3(1), 1609-1622
